Abstract:Background Obesity is associated with left atrial (LA) remodeling (ie, dilatation and dysfunction) which is an independent determinant of future cardiovascular events. We aimed to assess whether LA remodeling is present in obesity even in individuals without established cardiovascular disease and whether it can be improved by intentional weight loss. Methods and Results Forty‐five individuals with severe obesity without established cardiovascular disease (age, 45±11 years; body mass index; 39.1±6.7 kg/m 2 ; excess body weight, 51±18 kg) underwent cardiac magnetic resonance for quantification of LA and left ventricular size and function before and at a median of 373 days following either a low glycemic index diet (n=28) or bariatric surgery (n=17). Results were compared with those obtained in 27 normal‐weight controls with similar age and sex. At baseline, individuals with obesity displayed reduced LA reservoir function (a marker of atrial distensibility), and a higher mass and LA maximum volume (all P <0.05 controls) but normal LA emptying fraction. On average, weight loss led to a significant reduction of LA maximum volume and left ventricular mass (both P <0.01); however, significant improvement of the LA reservoir function was only observed in those at the upper tertile of weight loss (≥47% excess body weight loss). Following weight loss, we found an average residual increase in left ventricular mass compared with controls but no residual significant differences in LA maximum volume and strain function (all P >0.05). Conclusions Obesity is linked to subtle LA myopathy in the absence of overt cardiovascular disease. Only larger volumes of weight loss can completely reverse the LA myopathic phenotype. Nonstandard Abbreviations and Acronyms %EBW excess body weight percentage LAEF left atrial emptying fraction LAVmax left atrial maximum volume Clinical Perspective What Is New? A subtle left atrial dysfunction can be found in individuals affected by obesity even in the absence of overt cardiovascular disease and risk factors. Such left atrial myopathic phenotype can be completely reverted with large volumes of weight loss. What Are the Clinical Implications? When managing individuals with obesity, efforts to obtain large volumes of weight loss may be considered to reverse the early subtle left atrial dysfunction even in the absence of overt cardiovascular disease and risk factors. Obesity is independently associated with increased risk of heart failure, 1 , 2 atrial fibrillation (AF), 3 and thromboembolic events. 1 , 4 , 5 , 6 Typically, obesity is associated with cardiac remodeling characterized by left ventricular (LV) hypertrophy. 7 Recent evidence suggests that obesity appears to be linked to left atrial (LA) myopathic changes (in terms of LA dilatation 8 and dysfunction 9 ). This is relevant as convincing evidence now shows that LA dilatation and dysfunction (eg, lower LA reservoir function, a marker of reduced LA compliance) are associated with worse cardiovascular outcomes. 10 , 11 , 12 , 13 To date, it is unclear whether LA myopathy in obesity may be a downstream phenotype reflecting the higher burden of cardiovascular risk factors caused by obesity (eg, type 2 diabetes and hypertension) 1 or whether there are early LA myopathic changes (ie, onsetting before the cardiovascular complications of obesity occur) likely reflecting the systemic inflammation 14 and hemodynamic strain 15 associated with this condition. Although Mendelian randomization studies 16 have confirmed that an elevated body mass index (BMI) is causally linked to AF (sometimes regarded as an extreme form of atrial myopathy), it is unclear whether a weight loss intervention (through either a dietary intervention or bariatric surgery) would be sufficient to reverse the LA myopathic phenotype. Here, we used advanced cardiac magnetic resonance (CMR) imaging to assess (a) whether -Abstract Truncated-

Left atrial remodeling and voltage-guided ablation outcome in obese patients with persistent atrial fibrillation

Representation of Patients with Obesity in Atrial Fibrillation Ablation Trials: A Systematic Review

Left Atrial Volume Index Predicts Atrial Fibrillation Recurrence after Catheter Ablation Only in Obese Patients—Brief Report

Effect of Obesity on the Outcome of Catheter Ablation for Persistent Atrial Fibrillation

Obesity is associated with long-term outcome of catheter ablation of atrial fibrillation in patients with dilated cardiomyopathy

Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials

U-Shaped Relationship Between Left Atrium Size on Echocardiography and 1-Year Recurrence of Atrial Fibrillation after Radiofrequency Catheter Ablation - Prognostic Value Study -

Effect of Weight Loss on Early Left Atrial Myopathy in People With Obesity But No Established Cardiovascular Disease

Impact of obesity and early recurrence of atrial fibrillation on very late recurrence following cryoballoon pulmonary vein isolation

MRI-quantified left atrial epicardial adipose tissue predicts atrial fibrillation recurrence following catheter ablation

Left atrial epicardial adiposity and atrial fibrillation

Extra-Pulmonary Vein Driver Mapping And Ablation For Persistent Atrial Fibrillation In Obese Patients

The predictive value of left atrium epicardial adipose tissue on recurrence after catheter ablation in patients with different types of atrial fibrillation

Combination of Epicardial Adipose Tissue and Left Atrial Low-Voltage Areas Predicting Atrial Fibrillation Recurrence after Radiofrequency Ablation

Epicardial Adipose Tissue and Atrial Fibrillation Recurrence following Catheter Ablation: A Systematic Review and Meta-Analysis

The association of obesity and in-hospital outcomes among patients undergoing ablation for atrial fibrillation: a propensity-score matched analysis

Epicardial fat and atrial fibrillation: the perils of atrial failure

Association of Obesity Measures with Atrial Fibrillation Recurrence after Cryoablation in Patients with Paroxysmal Atrial Fibrillation

Left atrium remodeling predicts late recurrence of paroxysmal atrial fibrillation after second generation cryoballoon ablation

A U-shaped Relationship of Body Mass Index on Atrial Fibrillation Recurrence Post Ablation: A Report from the Guangzhou Atrial Fibrillation Ablation Registry

Quantification of epicardial adipose tissue in patients undergoing hybrid ablation for atrial fibrillation